Should You Buy Hexo Corp (TSX:HEXO) Ahead of Earnings?

Hexo Corp (TSX:HEXO) has been off to a good start this year, but whether that will continue will likely depend on how well it did during its most recent quarter.

| More on:
edit Cannabis leaves of a plant on a dark background

Image source: Getty Images

You’re reading a free article with opinions that may differ from The Motley Fool’s premium investing services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn moresdf

Hexo (TSX:HEXO) is expected to release its quarterly earnings later this week, and a good performance could send the stock soaring. Although the stock has risen more than 50% since the start of the year, Hexo is still far from the highs it hit back in October when it was trading at more than $9 per share.

The upcoming quarter is going to be a big one, as it will be the first quarter that earnings will include a full three months’ worth of recreational sales. In its most recent quarter, which included just a few weeks of post-legalization sales, Hexo saw revenues hit $6.7 million, up from just $1.1 million a year ago. Recreational sales of $5.2 million were the main drivers of the growth during the quarter, and that number will be much more significant now.

Why the bottom line might be more important

Investors are expecting sales growth to be significant this quarter, and Hexo stock getting a boost on earnings might very well depend on how close the company is able to get to breaking even. Rising expenses have been a big problem for many cannabis companies, and finding a marijuana stock that is able to stay out of the red, without relying on other income, is very difficult. And being able to do so is one way Hexo can differentiate itself from its peers and gain the attention of investors.

However, last quarter it recorded a net loss of over $12 million, nearly double its top line. If we see that trend continue this quarter, then the stock’s upside might be limited. With Hexo working on the development of beverages with Molson Coors, I wouldn’t expect to see its costs come down any time soon. The one positive is that the company hasn’t been knee deep in acquisitions like some other cannabis companies have been, which means Hexo can focus on its own operations and costs rather than having to worry about integrating other ones and incurring inefficiencies and high costs along the way.

A look at the company’s track record

In three of the past four quarters, Hexo has missed expectations, and the stock has gone on to drop in the days following earnings. Ironically, the one time the company did beat on earnings, it wasn’t enough to keep the stock from falling in price. However, that might not come as a shock, given that it’s usually what the company says about the future and its outlook that dictates price movement, at least in this industry.

Bottom line

Ultimately, there’s not enough evidence here to suggest to me that Hexo will buck the trend and turn a profit. While sales will definitely be up from a year ago, unless we see a big development or a positive update with respect to beverages, I’d be surprised if Hexo were to get a big boost from earnings.

This article represents the opinion of the writer, who may disagree with the “official” recommendation position of a Motley Fool premium service or advisor. We’re Motley! Questioning an investing thesis — even one of our own — helps us all think critically about investing and make decisions that help us become smarter, happier, and richer, so we sometimes publish articles that may not be in line with recommendations, rankings or other content.

Fool contributor David Jagielski has no position in any of the stocks mentioned. The Motley Fool owns shares of Molson Coors Brewing.

More on Cannabis Stocks

Cannabis smoke
Cannabis Stocks

Canopy Growth Stock: Is Now a Good Time to Invest?

The road ahead is highly uncertain for Canopy Growth, as the stock is plagued with losses and seemingly unsurmountable industry…

Read more »

Cannabis grows at a commercial farm.
Cannabis Stocks

TLRY Stock: Should You Invest Now?

TLRY is a Canadian cannabis stock which is trading 91% below record highs. Let's see if you should own TLRY…

Read more »

Cannabis grows at a commercial farm.
Cannabis Stocks

Is Tilray Stock a Buy in February 2023?

Despite the volatile cannabis sector, Tilray could be a superb buy for long-term investors.

Read more »

Young woman sat at laptop by a window
Cannabis Stocks

Is SNDL Stock a Buy in February 2023?

SNDL is a beaten-down cannabis stock. While its revenue growth is exceptional, a weak balance sheet has driven stock prices…

Read more »

A cannabis plant grows.
Cannabis Stocks

TLRY Stock: Here’s What’s Coming in 2023

Tilray Inc. (TSX:TLRY) is geared up for big growth this decade and looks like one of the top cannabis stocks…

Read more »

A person holds a small glass jar of marijuana.
Cannabis Stocks

Canopy Growth Stock: Here’s What’s Coming in 2023

Canopy Growth stock has made a lot of new moves in the last few months, but where is the company…

Read more »

A cannabis plant grows.
Cannabis Stocks

Better Cannabis Buy: Canopy Growth Stock or Tilray?

Only two TSX weed stocks can deliver substantial returns in the highly anticipated growth of the global cannabis market.

Read more »

Medicinal research is conducted on cannabis.
Cannabis Stocks

Is Tilray Stock a Buy in January 2023?

Tilray stock has lost 50% of its value in the last 12 months, in line with its peers.

Read more »